Frankfurt am Main, HE
60310
Germany
Fax: 49 69 907485-312
Overview
Martin Prokoph is a partner in the Private Equity and M&A practices at Paul Hastings and is based in the Frankfurt office. Mr. Prokoph represents private equity and corporate clients in a broad range of transactions, including leveraged buyouts, M&A, growth equity investments, corporate restructurings, joint ventures, and management incentive schemes. He has extensive experience in cross-border transactions, particularly those involving targets in the tech, pharma, and life sciences sector.
Accolades and Recognitions
Recognized in private equity and venture capital, JUVE AWARDS, 2020
Education
State of Berlin, Second State Exam, 2010
Deakin University (Australia), Master of International Finance, 2007
Humboldt-University Berlin, First State Exam, 2005
Speaking Engagements
Guest lecturer at Gottfried Wilhelm Leibniz University Hannover
Recent Representations
Nexelis Group Inc., a portfolio company of Ampersand Capital Partners, in the acquisition of the GSK vaccines clinical bioanalytical laboratory (Clinical Laboratory Science (CLS) Business) in Marburg, Germany.
HSRL Holdings LLC d/b/a StageBio, a portfolio company of Ampersand Capital Partners, in the acquisition of TPL Path Labs, a contract research organization (CRO) that conducts preclinical and clinical studies as a service provider in research and development of medical devices and drugs.
Ampersand Capital Partners in the acquisition of a majority stake in GeneWerk GmbH, a cell and gene therapy testing lab and a leading provider of vector integration site analysis.
Capital D in the sale of a majority stake in Invincible Brands' premium D2C portfolio companies HelloBody, Banana Beauty, and Mermaid+Me to Henkel.
PCI Pharma Services, a portfolio company of Partners Group and leading provider of pharmaceutical and biopharmaceutical supply chain solutions, in the acquisition of the Bellwyck Pharma Services group.
Neon Therapeutics (Nasdaq: NTGN) in its acquisition by BioNTech (Nasdaq: BNTX) through an all-stock transaction by way of merger.
ANSYS, Inc. a global leader of engineering simulation software, in its acquisition of the Dynardo group, a leading provider of simulation process integration and design optimization (PIDO) technology headquartered in Weimar, Germany.
Ampersand Capital Partners in the acquisition of Vibalogics GmbH, a development and manufacturing organization providing process development and GMP manufacturing services in the virotherapy field.
Onapsis Inc. in its acquisition of the Virtual Forge group, a leading provider of automated security solutions for SAP.
Vision Ophthalmology Group, a portfolio company of Stirling Square Capital Partners, in its acquisition of M.E.D Medical Products GmbH, a leading manufacturer of customized surgical kits.
Capital D in the acquisition of a majority stake in Invincible Brands UG (haftungsbeschränkt), a social media influencer-led D2C marketing and product development company.
Castlelake in various acquisitions and dispositions of real estate portfolios, including by way of a combined asset share and loan acquisition and debt-to-equity swaps.
Partners Group in the acquisition of a minority stake in a medical technology company.
Hartford Steam Boiler (HSB), a part of Munich RE, in its acquisition of relayr Inc. a Berlin-based Internet of Things (IoT) company.
Linxens in the acquisition of Smartrac's SIT division, a global leader in the development and manufacturing of RFID inlays and antennas.
Rossignol Group in the acquisition of the Felt Group, a leading bicycle manufacturer.